Image For Activity Cover
Workshop: Treatment of Alcohol Use Disorder (AUD) in Patients with Alcohol-Associated Liver Disease (ALD)

Excessive alcohol use leads to many preventable medical comorbidities with the most common being alcohol-associated liver disease (ALD)1. Alcohol addiction, or DSM-V defined alcohol use disorder (AUD), is being recognized by hepatologists and other physicians as a treatable condition to prevent ALD2.

Addiction specialists have an opportunity to help their hepatology colleagues but may not be familiar with AUD treatment in the setting of ALD. Novel multi-disciplinary clinics to manage both addiction and hepatology care together have been proposed and implemented to help addiction care to be incorporated into general medical practice3. AUD Treatment plans that can be more readily adopted by gastroenterologists and hepatologists will be essential.

Learning Objectives
  • Interpret the current knowledge on the safety and efficacy of individualized pharmacotherapy for AUD in ALD.
  • Recognize the proven psychotherapies for AUD and evaluate the role for innovative technology assisted interventions that are being offered to patients with AUD in the context of ALD.
  • Construct a bio-psycho-social-cultural approach to AUD treatment planning in the setting of ALD.
Keywords / Topics
  • Alcohol
  • Cirrhosis
  • psychopharmacology
Akhil Shenoy, MD MPH, Chairperson and Presenter
Akhil Shenoy MD MPH is the Director of Transplant Psychiatry at Columbia University Medical Center and an Associate Professor of Psychiatry. 

Candace Hatten-Powell, MD, Presenter

Candace Hatten-Powell, MD completed B.S. at Cornell University’s College of Human Ecology in Human Biology, Health, and Society with a minor in Policy Analysis and Management. She completed her Doctor of Medicine degree at SUNY Upstate Medical University and completed residency at Montefiore Medical Center in General Psychiatry, where she served as chief resident in the Psychiatric Observation Suite in the subspecialty of emergency psychiatry. 
Mashal Khan, MD, Presenter

Mashal Khan, M.D. is an Assistant Professor of Clinical Psychiatry at NewYork Presbyterian-Weill Cornell Medicine, where he works along with the Liver Transplant Team. He also serves as the Associate Program Director for the Addiction Psychiatry Fellowship.
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
American Academy of Addiction Psychiatry
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

400 Massasoit Avenue
Suite 307
East Providence, RI 02914

Education and Resources
Training Events

Powered By